The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Open accessAbstract
Dendritic cells (DCs) play a pivotal role in the tumor microenvironment, which is known to affect disease progression in many human malignancies. Infiltration by mature, active DCs into the tumors confers an increase in immune activation and recruitment of disease-fighting immune effector cells and pathways. DCs are the preferential target of infiltrating T cells. However, tumor cells have means of suppressing DC function or of altering the tumor microenvironment in such a way that immune-suppressive DCs are recruited. Advances in understanding these changes have led to promising developments in cancer-therapeutic strategies targeting tumor-infiltrating DCs to subdue their immunosuppressive functions and enhance their immune-stimulatory capacity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
Watkins, S. K., Zhu, Z., Riboldi, E., Shafer-Weaver, K., Stagliano, K. E., Sklavos, M. M., Ambs, S., Yagita∥, H., & Hurwitz, A. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44325 · Cited by 137
RetractedPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Self-citationSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Sato, E., Olson, S. H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,372
Mouse and human dendritic cell subtypes
Shortman, K., & Liu, Y.-J. (2002) · Nature Reviews Immunology · doi:10.1038/nri746 · Cited by 2,291
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Up on the tightrope: natural killer cell activation and inhibition
Lanier, L. L. (2008) · Nature Immunology · doi:10.1038/ni1581 · Cited by 1,656
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?
Lutz, M. B., & Schuler, G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02281-0 · Cited by 1,349
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Self-citationRodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., & Iacopetta, B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 991
Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M., Nacken, W., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 902
Kusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.989 · Cited by 850
Chiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Fujioka, Y., Ohba, Y., Gorman, J. V., Colgan, J. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2376 · Cited by 838
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Facciabene, A., Motz, G. T., & Coukos, G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3687 · Cited by 821
The who, how and where of antigen presentation to B cells
Batista, F. D., & Harwood, N. E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2454 · Cited by 775
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., Mackensen, A., & Kreutz, M. (2006) · Blood · doi:10.1182/blood-2005-05-1795 · Cited by 729
Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer—Response
Sznol, M., & Chen, L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2234 · Cited by 528
Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
Sznol, M., & Chen, L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2063 · Cited by 488
WHITESIDE, T. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.008 · Cited by 487
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer
Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R., & Gabrilovich, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.464 · Cited by 464
Chen, W., Liang, X., Peterson, A. J., Munn, D. H., & Blazar, B. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5396 · Cited by 453
Görgün, G. T., Whitehill, G., Anderson, J. L., Hideshima, T., Maguire, C., Laubach, J., Raje, N., Munshi, N. C., Richardson, P. G., & Anderson, K. C. (2013) · Blood · doi:10.1182/blood-2012-08-448548 · Cited by 393
Wang, L., Pino-Lagos, K., de Vries, V. C., Guleria, I., Sayegh, M. H., & Noelle, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710441105 · Cited by 389
Dendritic Cells in the Cancer Microenvironment
Ma, Y., Shurin, G. V., Peiyuan, Z., & Shurin, M. R. (2013) · Journal of Cancer · doi:10.7150/jca.5046 · Cited by 361
Jochems, C., & Schlom, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011007 · Cited by 353
Sisirak, V., Faget, J., Gobert, M., Goutagny, N., Vey, N., Treilleux, I., Renaudineau, S., Poyet, G., Labidi-Galy, S. I., Goddard-Leon, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3468 · Cited by 345
Vicari, A. P., Chiodoni, C., Vaure, C., Aït-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020732 · Cited by 343
Engelhardt, J. J., Boldajipour, B., Beemiller, P., Pandurangi, P., Sorensen, C., Werb, Z., Egeblad, M., & Krummel, M. F. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.008 · Cited by 330
Immune microenvironments in solid tumors: new targets for therapy
Shiao, S. L., Ganesan, A. P., Rugo, H. S., & Coussens, L. M. (2011) · Genes & Development · doi:10.1101/gad.169029.111 · Cited by 322
Ovarian cancer progression is controlled by phenotypic changes in dendritic cells
Scarlett, U. K., Rutkowski, M. R., Rauwerdink, A. M., Fields, J., Escovar-Fadul, X., Baird, J., Cubillos-Ruiz, J. R., Jacobs, A. C., Gonzalez, J. L., Weaver, J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111413 · Cited by 315
Conrad, C., Gregorio, J., Wang, Y.-H., Ito, T., Meller, S., Hanabuchi, S., Anderson, S., Atkinson, N., Ramirez, P. T., Liu, Y.-J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2271 · Cited by 314
Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
Anderson, A. C. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0039 · Cited by 305
CD86 and CD80 Differentially Modulate the Suppressive Function of Human Regulatory T Cells
Zheng, Y., Manzotti, C. N., Liu, M., Burke, F., Mead, K. I., & Sansom, D. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2778 · Cited by 279
Dendritic Cells Infiltrating Human Non-Small Cell Lung Cancer Are Blocked at Immature Stage
Perrot, I., Blanchard, D., Freymond, N., Isaac, S., Guibert, B., Pachéco, Y., & Lebecque, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2763 · Cited by 266
Cytokines and Immune Response in the Tumor Microenvironment
Mocellin, S., Wang, E., & Marincola, F. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200109000-00002 · Cited by 259
Krempski, J., Karyampudi, L., Behrens, M. D., Erskine, C. L., Hartmann, L., Dong, H., Goode, E. L., Kalli, K. R., & Knutson, K. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100274 · Cited by 251
Self-citationCanioni, D., Salles, G., Mounier, N., Brousse, N., Keuppens, M., Morchhauser, F., Lamy, T., Sonet, A., Rousselet, M.-C., Foussard, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.8298 · Cited by 247
The significant role of mast cells in cancer
Khazaie, K., Blatner, N. R., Khan, M. W., Gounari, F., Gounaris, E., Dennis, K., Bonertz, A., Tsai, F.-N., Strouch, M. J., Cheon, E., et al. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9286-z · Cited by 222
Preston, C. C., Maurer, M. J., Oberg, A. L., Visscher, D. W., Kalli, K. R., Hartmann, L. C., Goode, E. L., & Knutson, K. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080063 · Cited by 208
Self-citationTim-3, a negative regulator of anti-tumor immunity
Anderson, A. C. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.005 · Cited by 204
Tim-3: An Activation Marker and Activation Limiter of Innate Immune Cells
Han, G., Chen, G., Shen, B., & Li, Y. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00449 · Cited by 198
Shen, Z., Zhou, S., Wang, Y., Li, R.-L., Zhong, C., Liang, C., & Sun, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0816-9 · Cited by 195
Inflammation-related factors predicting prognosis of gastric cancer
Chang, W.-J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4586 · Cited by 193
Tumor-Educated CD11bhighIalow Regulatory Dendritic Cells Suppress T Cell Response through Arginase I
Liu, Q., Zhang, C., Sun, A., Zheng, Y., Wang, L., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803926 · Cited by 186
Division of labor, plasticity, and crosstalk between dendritic cell subsets
Pulendran, B., Tang, H., & Denning, T. L. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.10.009 · Cited by 166
Karyampudi, L., Lamichhane, P., Scheid, A. D., Kalli, K. R., Shreeder, B., Krempski, J. W., Behrens, M. D., & Knutson, K. L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2564 · Cited by 162
Self-citationCubillos‐Ruiz, J. R., Baird, J. R., Tesone, A. J., Rutkowski, M. R., Scarlett, U. K., Camposeco-Jacobs, A. L., Anadon-Arnillas, J., Harwood, N. M., Korc, M., Fiering, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3160 · Cited by 149
Luo, Z., Wang, C., Yi, H., Li, P., Pan, H., Liu, L., Cai, L., & Ma, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.050 · Cited by 142
Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor Immunity
Hargadon, K. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00192 · Cited by 140
Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer
Michielsen, A. J., Hogan, A. E., Marry, J., Tosetto, M., Cox, F., Hyland, J. M., Sheahan, K. D., O’Donoghue, D. P., Mulcahy, H. E., Ryan, E. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027944 · Cited by 140
Lin, A., Schildknecht, A., Nguyen, L. T., & Ohashi, P. S. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.09.003 · Cited by 135
CD8+ Tumor-Infiltrating T Cells Are Trapped in the Tumor-Dendritic Cell Network
Boissonnas, A., Licata, F., Poupel, L., Jacquelin, S., Fetler, L., Krumeich, S., Théry, C., Amigorena, S., & Combadière, C. (2013) · Neoplasia · doi:10.1593/neo.121572 · Cited by 117
Sevko, A., & Umansky, V. (2013) · Journal of Cancer · doi:10.7150/jca.5047 · Cited by 104
Inactivation of tumor‐specific CD8+ CTLs by tumor‐infiltrating tolerogenic dendritic cells
Harimoto, H., Shimizu, M., Nakagawa, Y., Nakatsuka, K., Wakabayashi, A., Sakamoto, C., & Takahashi, H. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.38 · Cited by 100
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells
Stoitzner, P., Green, L. K., Jung, J. Y., Price, K. M., Atarea, H., Kivell, B. M., & Ronchese, F. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0487-4 · Cited by 96
Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation
Chistiakov, D. A., Sobenin, I. A., Orekhov, A. N., & Bobryshev, Y. V. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.12.010 · Cited by 95
Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events
Gastman, B., Johnson, D. E., Whiteside, T. L., & Rabinowich, H. (2000) · Blood · doi:10.1182/blood.v95.6.2015 · Cited by 91
Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation
Chistiakov, D. A., Orekhov, A. N., Sobenin, I. A., & Bobryshev, Y. V. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00279 · Cited by 90
Fukaya, T., Takagi, H., Sato, Y., Sato, K., Eizumi, K., Taya, H., Shin, T., Chen, L., Dong, C., Azuma, M., et al. (2010) · Blood · doi:10.1182/blood-2009-10-250472 · Cited by 78
Deciphering the Message Broadcast by Tumor-Infiltrating Dendritic Cells
Karthaus, N., Torensma, R., & Tel, J. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.05.012 · Cited by 78
High expression of FOXP3 in primary melanoma is associated with tumour progression
Gerber, A., Münst, A., Schlapbach, C., Shafighi, M., Kiermeir, D., H�usler, R., & Hunger, R. E. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12641 · Cited by 72
Immunosuppressive Factors: Role in Cancer Development and Progression
Botti, C., Seregni, E. C., Ferrari, L., Martinetti, A., & Bombardieri, E. (1998) · The International Journal of Biological Markers · doi:10.1177/172460089801300201 · Cited by 63
Maurya, N., Gujar, R., Gupta, M., Yadav, V., Verma, S., & Sen, P. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400395 · Cited by 62
Origin and pharmacological modulation of tumor‐associated regulatory dendritic cells
Zhong, H., Gutkin, D. W., Han, B., Ma, Y., Keskinov, A. A., Shurin, M. R., & Shurin, G. V. (2014) · International Journal of Cancer · doi:10.1002/ijc.28590 · Cited by 61
Min, S., Liang, X., Zhang, M., Zhang, Y., Mei, S., Liu, J., Liu, J., Su, L., Cao, S., Zhong, X., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202282 · Cited by 55
Darrasse-Jèze, G., & Podsypanina, K. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00292 · Cited by 54
Kocián, P., Šedivcová, M., Drgáč, J., Černá, K., Hoch, J., Kodet, R., Bartůňková, J., Špíšek, R., & Fialová, A. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.07.312 · Cited by 54
The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma: A Single Institution Study
Ganjoo, K. N., Witten, D., Patel, M., Espinosa, Í., La, T. H., Tibshirani, R. J., van de Rijn, M., Jacobs, C., & West, R. B. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181d26d5e · Cited by 40
What Are the Molecules Involved in Regulatory T-Cells Induction by Dendritic Cells in Cancer?
Ramos, R. N., de Moraes, C. J., Zelante, B., & Barbuto, J. A. M. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/806025 · Cited by 33
Melanoma-infiltrating dendritic cells
Klarquist, J. S., & Janssen, E. M. (2012) · OncoImmunology · doi:10.4161/onci.22660 · Cited by 31
Cited by
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Metabolic Reprogramming of Immune Cells in Cancer Progression
Biswas, S. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.001 · Cited by 721
Metadata
- Authors
- Tran Janco, J. M., Lamichhane, P., Karyampudi, L., & Knutson, K. L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-01
- Volume
- 194
- Issue
- 7
- Pages
- 2985-2991
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1823780969
- Cited by
- 440
- References
- 81
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.